Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Código QR

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Vidya H Veldore,1,* Anuradha Choughule,2,* Tejaswi Routhu,1 Nitin Mandloi,1 Vanita Noronha,2 Amit Joshi,2 Amit Dutt,3 Ravi Gupta,1 Ramprasad Vedam,1 Kumar Prabhash2 1MedGenome Labs Private Ltd,, Bangalore, India; 2Tata Memorial Centre, Parel, Mumbai, India; 3The Advanced Centre for Treatment, Resear...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Liquid Biopsy NSCLC EGFR ctDNA NGS Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/75a83c5f0528444c8a9f3e281fae022b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma
por: Kate I. Glennon, et al.
Publicado: (2021)

Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
por: Natasha Honoré, et al.
Publicado: (2021)

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
por: Maha Elazezy, et al.
Publicado: (2021)

Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
por: Lionel Larribère, et al.
Publicado: (2021)

Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
por: Kate S, et al.
Publicado: (2019)

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer
por: T. Hedley Carr, et al.
Publicado: (2021)

Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review
por: Markéta Hudečková, et al.
Publicado: (2021)

Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
por: Paola Ulivi, et al.
Publicado: (2021)

Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature
por: Klempner SJ, et al.
Publicado: (2017)

Biopsy of lung lesions under CT control
por: Miloslav Marel, et al.
Publicado: (2021)

Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature
por: Michela Verzè, et al.
Publicado: (2021)

Liquid biopsy. A challenge for clinical laboratories
por: Jiménez Wladimiro
Publicado: (2020)

Role of afatinib in the treatment of advanced lung squamous cell carcinoma
por: Vavalà T
Publicado: (2017)

AZD3759 enhances radiation effects in non-small-cell lung cancer by a synergistic blockade of epidermal growth factor receptor and Janus kinase-1
por: Ruing Zhao, et al.
Publicado: (2021)

Plasma-Based Genotyping in Advanced Solid Tumors: A Comprehensive Review
por: Maisam Makarem, et al.
Publicado: (2021)

Identification of lncRNA–miRNA–mRNA Networks Linked to Non-small Lung Cancer Resistance to Inhibitors of Epidermal Growth Factor Receptor
por: Ting Wang, et al.
Publicado: (2021)

Research Progress on CircRNA in Liquid Biopsy of Gastric Cancer
por: ZHU Hao, et al.
Publicado: (2021)

Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer
por: Arlou Kristina Angeles, et al.
Publicado: (2021)

Liquid Biopsy and Primary Brain Tumors
por: Robert H. Eibl, et al.
Publicado: (2021)

Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer
por: Wen J, et al.
Publicado: (2021)

The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
por: Chung Un Lee, et al.
Publicado: (2021)

Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
por: Marinus Huber, et al.
Publicado: (2021)

Liquid Biopsy in Prostate Cancer Diagnosis and Prognosis: A Narrative Review
por: Seyed Saeed Tamehri Zadeh, et al.
Publicado: (2020)

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
por: Yurong Wang, et al.
Publicado: (2021)

Severe hyponatremia due to paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in non-small cell lung carcinoma transforming to small cell lung carcinoma during treatment with immune checkpoint inhibitor
por: Vicky Mai, et al.
Publicado: (2021)

Detection Technology and Prospects of Clinical Application of Circulating Tumor Cells in Pancreatic Cancer
por: YANG Xiaoying, et al.
Publicado: (2021)

Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine
por: Arechederra María, et al.
Publicado: (2020)

Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
por: Marta Łukasiewicz, et al.
Publicado: (2021)

Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors
por: Argyris C. Hadjimichael, et al.
Publicado: (2021)

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report
por: Lander Van Acker, et al.
Publicado: (2021)

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer
por: Akiko Takahashi, et al.
Publicado: (2018)

The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
por: Neuberger J, et al.
Publicado: (2021)

Diagnostic yield and safety of closed needle pleural biopsy in exudative pleural effusion
por: Govind Singh Rajawat, et al.
Publicado: (2017)

Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
por: Sánchez-Herrero Estela, et al.
Publicado: (2020)

Gasless Laparoscopic Anatomy and Renal Biopsy of the Kidney in the Standing Mare
por: Kassem,Mostafa M, et al.
Publicado: (2014)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Hitomi Sumiyoshi Okuma, et al.
Publicado: (2021)

High-Throughput Miniaturized 16S rRNA Amplicon Library Preparation Reduces Costs while Preserving Microbiome Integrity
por: Jeremiah J. Minich, et al.
Publicado: (2018)

Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
por: Zhang SS, et al.
Publicado: (2021)

Case Report: Dacomitinib Overcomes Osimertinib Resistance in NSCLC Patient Harboring L718Q Mutation: A Case Report
por: Qian Shen, et al.
Publicado: (2021)

Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
por: Gribko A, et al.
Publicado: (2019)